Cite
HARVARD Citation
Doria, A. et al. (n.d.). LB0001 Efficacy and Safety of Subcutaneous Belimumab plus Standard Care in Patients with Systemic Lupus Erythematosus (SLE) with Low Complement and Positive Anti-DSDNA. Annals of the rheumatic diseases. pp. 70-71. [Online].